Symptom Guides

Who Needs B12 Injections? Choosing Between Injections and Tablets

B12 injections are needed for life in autoimmune gastritis, when the stomach has been completely removed or when the end of the small intestine has been removed. For other causes, tablets can also work.

14 May 2026 · Updated 26 October 2026 · 11 min read · Doktorclub Health Editors

Translated from the Turkish original by Doktorclub. The Turkish version is the reference text; this English translation has not been separately reviewed by a physician. Read the Turkish original.

Who Needs B12 Injections? Choosing Between Injections and Tablets

Key takeaway

B12 injections are needed most by people who permanently cannot absorb B12 from the gut. The NICE NG239 (2024) guideline recommends lifelong intramuscular B12 in three situations. These are autoimmune gastritis (pernicious anemia), removal of the whole stomach and complete removal of the last part of the small intestine. The Turkish Society of Hematology (THD) 2025 guideline recommends starting treatment with injections if nerve findings also accompany the symptoms of anemia. In deficiency due to diet or a medicine, tablets are also an option. Having an injection only for tiredness or "energy", without the deficiency being confirmed, is not right. If your doctor has recommended injections, do not switch to tablets on your own. If you have numbness, loss of balance or a walking problem, see a doctor the same day, without waiting.

Short Answer

B12 injections are needed for life in autoimmune gastritis, when the stomach has been completely removed or when the end of the small intestine has been removed. For other causes, tablets can also work.

This recommendation is based on the UK's NICE NG239 (2024) guideline. The Turkish Society of Hematology (THD 2025) recommends starting treatment with injections if there are nerve findings together with anemia. In deficiency due to diet or a medicine, high-dose tablets can also be used.

First the deficiency needs to be confirmed. What your result means is explained in the threshold table in the B12 deficiency guide. Blood should be drawn before the injection; a test done after the injection hides the deficiency (NICE 2024).

Injection or tablet? A decision table by cause

The table below summarizes the NICE NG239 recommendations. Your doctor sets the dose and frequency by prescription.

Cause of the deficiencyRoute according to NICE 2024How long does it last?
Autoimmune gastritis (pernicious anemia), complete removal of the stomach, complete removal of the end of the small intestineIntramuscular injectionFor life; it continues even if symptoms go away.
Partial stomach surgery, some obesity surgeries, celiac diseaseInjection is considered. If tablets are chosen, at least 1 mg a day.Major stomach surgery and most obesity surgeries are a permanent cause; generally for life. For causes that can improve, such as celiac disease, it is reviewed at follow-up.
Due to a medicine (metformin, stomach acid suppressants)Injection or tablet; the doctor's assessment and your preference. According to NICE, treatment can also start while the test result is awaited.As long as the medicine continues. It is reviewed if the medicine is stopped and no symptoms remain.
Recreational laughing gasInjection or tablet; use should be stoppedIt is reviewed if use ends and no symptoms remain.
Due to dietMostly tabletsIt can be stopped once the diet improves. If a vegan diet continues, a constant source of B12 is needed.
Cause unknown, no absorption problem suspectedTablets; response is assessed at the first follow-upDecided at the first follow-up.
No deficiency; an "energy shot" for tirednessNot needed. Other causes of tiredness are investigated.–

When does the injection come to the fore even in deficiency due to diet?

NICE recommends considering injections instead of tablets in the following situations (recommendation 1.5.16):

  • If there is a condition that could worsen rapidly: loss of balance (ataxia) or anemia.
  • If taking tablets regularly is difficult: older age, a recent hospital stay, multiple illnesses, frailty, delirium, cognitive impairment or homelessness.

Seek care without waiting

  • Swelling of the face or tongue, widespread hives, shortness of breath after the injection: it may be a severe allergy; call 112 (in Türkiye) or your local emergency number.
  • Rapidly increasing numbness or being unable to walk, or muscle weakness or palpitations in the first days of treatment: go to the emergency department the same day. The full list is in the symptoms section of the B12 deficiency guide.

How are tablets used?

  • Dose level: If tablets are chosen in malabsorption, NICE recommends at least 1 mg (1,000 µg) a day (recommendation 1.5.5). In pregnancy and breastfeeding, at least 1 mg a day is also considered (recommendation 1.5.15). These doses are much higher than the amounts in multivitamins. Your doctor sets the dose.
  • Note for Türkiye: The oral medicines with 1 mg of B12 that the Social Security Institution (SGK) reimburses are combination tablets. Each tablet also contains 250 mg of B1 and 250 mg of B6. According to the product information of one of these tablets, it is not used in pregnancy, in breastfeeding, under age 18, or in kidney or liver failure; it is generally used for a few weeks. Ask your doctor which product to use in pregnancy.
  • Why does it work? According to THD 2025, part of B12 taken at a high dose is absorbed by the passive route without the need for intrinsic factor. So it can be effective even in malabsorption. NICE, however, recommends injections in autoimmune gastritis; in this group, choose the route with your doctor.
  • When is it taken? The NHS writes that in deficiency due to diet the tablet can be taken every day between meals.
  • Type of product: If a non-prescription product is to be used, NICE recommends that it contain cyanocobalamin, methylcobalamin or adenosylcobalamin. The word "sublingual" on its own does not show superiority. For the label, see how to read a supplement label
  • What is asked at follow-up? NICE recommends asking whether you are really taking the tablet at the right dose. If symptoms do not improve enough, the dose is raised to the highest licensed level. If you are already on the highest dose, a switch to injections is made (recommendation 1.6.4).

How do injections proceed? Türkiye and UK comparison

The injection schedule varies from country to country. The table below puts the Turkish guideline and practice in the UK side by side. Your doctor sets your own schedule.

TopicTürkiye (THD 2025)UK (NHS)
Ampoule usedA 1,000 µg cyanocobalamin ampoule or a combination ampoule containing hydroxocobalamin. The licensed hydroxocobalamin ampoules also contain B1, B6 and lidocaine, which numbs the injection site.Hydroxocobalamin; preferred because it stays in the body longer
StartThere is no single regimen. In one of THD's examples the injection is given every day in the first week, then 2 days a week for 2 weeks, then once a week for 1–2 weeks; after that it moves to once a month.Injections every other day in the initial period
MaintenanceCyanocobalamin once a month; hydroxocobalamin once every two to three monthsFor causes other than diet, once every 2–3 months for life
If there are nerve findingsIf they occur together with symptoms of anemia, treatment is started with injections. Once symptoms go away, a switch to oral treatment is possible.Referral to hematology; injections may come down to once every 2 months
Deficiency due to dietOnce the findings improve, the requirement is met with food or a multivitaminA tablet every day or two injections a year
  • How much stays in the body? According to THD 2025, about 150 µg of 1,000 µg of cyanocobalamin stays in the body; the rest is passed in the urine. With hydroxocobalamin the portion that stays is larger.
  • Repeating the test at follow-up: NICE does not recommend repeating the initial diagnostic test in a person receiving injections (recommendation 1.6.10). At follow-up, symptoms are looked at.
  • If symptoms do not go away: NICE recommends increasing the frequency of injections in line with the product information and considering other diagnoses.
  • Self-injection at home: NICE does not yet recommend this; it has only made a research recommendation.

Where is the injection given, and does it hurt?

The B12 injection is given into the muscle. The combination ampoules with hydroxocobalamin in Türkiye also contain lidocaine, a medicine that numbs the area (a local anesthetic); the product information lists pain at the injection site as a possible side effect. Single-ingredient 1,000 µg cyanocobalamin ampoules, on the other hand, contain only B12. If you have previously had an allergy to a local anesthetic or to a B12 injection, say so before the injection.

Prescription and SGK: B12 ampoules are prescription medicines. The 1,000 µg cyanocobalamin ampoules and the combination ampoules with hydroxocobalamin are on SGK's reimbursement list. In the Health Implementation Communiqué (SUT) there is no separate medical report requirement for B12; the usual medicine co-payment applies. There is no oral medicine containing B12 alone on the list (SUT Annex 4/A, October 2026).

Evidence: are tablets as effective as injections?

StudyWho, and how long?FindingLimitation
Cochrane 20183 randomized trials, 153 people; 3–4 monthsTablets of 1,000 µg a day were not found to be clinically different from injections in correcting the blood level.Evidence is of low certainty. Symptoms and quality of life were not measured.
OB12 (2020)283 people over age 65 in Spain; 52 weeksAt week 8, more than 90% in both groups reached a normal level. At week 52 the rate of normal levels was 73.6% with tablets and 80.4% with injections.After week 8 the tablet group moved to 1 mg once a week and the injection group to 1 mg once a month. 83.4% of participants preferred the oral route.

What does it mean? Tablets can correct the blood level in the short term in a way similar to injections. In OB12, the difference at week 52 was significant in the analysis of those who completed treatment. It was not significant in the analysis of everyone who was randomized. Moreover, the tablet group took a weekly, not a daily, dose in maintenance. So neither the verdict "tablets are worse" nor the verdict "tablets are equal" is certain. In severe nerve findings and in permanent loss of absorption, injections have a separate place.

When does it work? Timeline

According to NICE 2024, symptoms can start to improve within 2 weeks, but this can take up to 3 months. At the start of treatment, symptoms may increase for a short time; this generally passes.

TimeExpected change (THD 2025)
Days 1–2You start to feel better. Reticulocytes (young red blood cells) start to rise.
Day 5The rise in reticulocytes becomes marked; MMA and homocysteine start to fall.
Week 2Tongue and digestive complaints improve; nerve findings start to improve.
Weeks 2–3Homocysteine and MMA return fully to normal.
Weeks 6–8The blood count and red cell indices return to normal.

Nerve findings improve more slowly; long-standing damage may not go away completely. Follow-up dates and the rules for repeating tests are in the follow-up schedule in the B12 deficiency guide.

Side effects and safety

  • Allergy: According to THD 2025, anaphylaxis can rarely develop after B12 treatment. It has been reported more often with hydroxocobalamin.
  • Fall in potassium: In severe deficiency, THD recommends starting treatment at a low dose and monitoring in the first days.
  • Folic acid: In B12 deficiency, folic acid on its own is inadvisable; see low folate.
  • Too much B12: According to the NIH Office of Dietary Supplements (NIH ODS), there is no upper intake limit for B12. EFSA does not report a defined adverse effect either. THD notes that long-term high-dose oral use has been associated with some cancers. NIH ODS says the evidence on this is conflicting. Avoid unnecessarily high doses.
  • Cobalamin resistance: According to THD 2025, the response to B12 may be reduced in diabetes and kidney failure.
  • Combination ampoules: The hydroxocobalamin ampoules in Türkiye also contain B6; the licensed name of one states 100 mg of B6 per ampoule. With closely spaced injections, or if you use another product containing B6, discuss the total with your doctor: B6 excess and neuropathy.

Who should be careful?

  • Pregnancy and breastfeeding: Treatment started before pregnancy is continued (NICE 2024). However, according to their product information, the combination ampoules with hydroxocobalamin in Türkiye are not used in pregnancy and breastfeeding because they contain high B6. If you are pregnant or breastfeeding, ask your doctor which ampoule is suitable. The rules on testing and starting injections in pregnancy are in the special groups section of the B12 deficiency guide. Do your follow-up with your obstetrician.
  • People taking metformin: The UK medicines regulator MHRA (2022) recommends that metformin be continued if there is no objection to it, and that the deficiency be treated separately. Do not stop your diabetes medicine yourself. For monitoring, see metformin and B12.
  • People who have had obesity surgery: Most operations are a permanent cause. See vitamin deficiency after obesity surgery.
  • Older people: If keeping up with tablets is difficult, injections are considered (NICE 2024).
  • Children: NICE NG239 is for those over age 16. In a child, the pediatrician plans treatment. The combination ampoules with hydroxocobalamin contain benzyl alcohol; according to the product information they are not given to newborns and are not recommended for children.
  • People with nerve findings: If numbness or a walking problem persists, a Neurology evaluation is needed; in severe anemia, a Hematology evaluation.

To check for interactions with the medicines you take, you can use the drug interaction tool.

When can treatment be stopped?

  • If there is a permanent cause (autoimmune gastritis, major stomach surgery, removal of the end of the small intestine, most obesity surgeries): NICE recommends lifelong injections even if symptoms go away.
  • If the cause has gone (the diet has improved, the medicine has been stopped, laughing gas use has ended) and symptoms have gone away: NICE recommends considering stopping treatment or making it less frequent.
  • If the cause continues or is unknown: Treatment continues and a new follow-up date is set.

According to THD 2025, if the cause cannot be eliminated, B12 is used for life. If symptoms return after the decision to stop, see a doctor.

Common mistakes

  • "Any B12 medicine is fine in pregnancy too." In Türkiye, the 1 mg oral B12 medicine reimbursed by SGK and the combination ampoules with hydroxocobalamin are not used in pregnancy according to their product information. Make the choice with your doctor.
  • "My symptoms have gone, I can stop the injections." In autoimmune gastritis and major stomach surgery the cause is permanent. If treatment is stopped, the deficiency can develop again.
  • "The doctor gave me injections but tablets are easier, I'll switch myself." Make a change of route with your doctor. NICE recommends injections in permanent loss of absorption.
  • "The sublingual or methyl type is absorbed better." NICE accepts all three types. What is decisive is the dose and regular use.
  • "I'm tired, let me get an energy shot." If there is no deficiency, there is no guideline recommendation showing that the injection provides additional benefit.
  • "Let me use the B complex ampoule and the tablets together." The total B6 in the contents can exceed the upper limit. Show the boxes to your doctor or pharmacist; the supplement check tool can also help.

What changed?

  • October 24, 2026: The page was reorganized around the "injection or tablet" decision. A table comparing injection schedules in Türkiye and the UK, the contents of ampoules and tablets in Türkiye, SGK reimbursement information and a list of common mistakes were added. B12 thresholds and the follow-up schedule are in the B12 deficiency guide.
  • October 23, 2026: NICE's recommendation of tablets of at least 1 mg a day in malabsorption and in pregnancy, the step of switching to injections if tablets are not enough, and the maintenance dose of the OB12 trial were added.
  • The treatment route was written according to the NICE NG239 (2024) recommendations; for Türkiye, the Turkish Society of Hematology 2025 guideline was added.

Sources added in this update

  1. NHS. Vitamin B12 or folate deficiency anaemia – Treatment. https://www.nhs.uk/conditions/vitamin-b12-or-folate-deficiency-anaemia/treatment/ (accessed October 24, 2026)
  2. EFSA. Overview on Tolerable Upper Intake Levels as derived by the SCF and the EFSA NDA Panel. https://www.efsa.europa.eu/sites/default/files/2024-05/ul-summary-report.pdf (accessed October 23, 2026)
  3. Social Security Institution (SGK). Sağlık Uygulama Tebliği Ek-4/A Bedeli Ödenecek İlaçlar Listesi [Health Implementation Communiqué Annex 4/A List of Reimbursed Medicines] (incorporating the amendment in the Official Gazette (Resmî Gazete) of October 2, 2026, No. 33388). https://sgk.gov.tr/duyuru/detay/02102026-Tarihli-ve-33388-Sayili-Resm-Gazetede-Yayimlanan-Sosyal-Guvenlik-Kurumu-Saglik-Uygulama-Tebliginde-Degisiklik-Yapilmasina-Dair-Teblig-2026-10-02-02-48-55 (accessed October 24, 2026)
  4. Turkish Medicines and Medical Devices Agency (TİTCK). Vitamin B1, B6 and B12 combination film-coated tablet (250 mg/250 mg/1 mg) Summary of Product Characteristics, sections 2, 4.2 and 4.9. TİTCK-approved SmPC (PDF) (accessed October 24, 2026)
  5. TİTCK. SKRS E-Reçete İlaç ve Diğer Farmasötik Ürünler Listesi ve Ruhsatlı Beşeri Tıbbi Ürünler Listesi [SKRS E-Prescription List of Medicines and Other Pharmaceutical Products and List of Licensed Medicinal Products for Human Use] (hydroxocobalamin combinations, ATC B03BA53). https://www.titck.gov.tr/dinamikmodul/43 (accessed October 24, 2026)
  6. TİTCK. Summaries of Product Characteristics of combination IM ampoules containing hydroxocobalamin, B6, B1 and lidocaine (two products), sections 2, 4.2, 4.3 and 4.6. TİTCK-approved SmPC 1 (PDF); TİTCK-approved SmPC 2 (PDF) (accessed October 24, 2026)

Sources

  1. Turkish Society of Hematology. Eritrosit Hastalıkları ve Hemoglobin Bozuklukları Tanı ve Tedavi Kılavuzu (B12 Vitamini Eksikliği bölümü) [Guideline for the Diagnosis and Treatment of Red Blood Cell Diseases and Hemoglobin Disorders (Vitamin B12 Deficiency chapter)]. Version 1.4, August 2025. https://file.thd.org.tr/file/ER%C4%B0TROS%C4%B0T-KILAVUZ-2025-.pdf (accessed October 23, 2026)
  2. Ministry of Health of Türkiye, General Directorate of Health Services (SHGM). Tıbbi Biyokimya Toplam Test Süreci Rehberi (Akılcı Test İstemi Listesi) [Guide to the Total Testing Process in Medical Biochemistry (Rational Test Ordering List)]. May 2024. https://dosyamerkez.saglik.gov.tr/Eklenti/48692/0/tibbi-biyokimya-toplam-test-sureci-rehberipdf.pdf (accessed October 23, 2026)
  3. NICE. Vitamin B12 deficiency in over 16s: diagnosis and management (NG239). March 2024. https://www.nice.org.uk/guidance/ng239/chapter/Recommendations (accessed October 23, 2026)
  4. Wang H et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev 2018;3:CD004655. https://doi.org/10.1002/14651858.CD004655.pub3 (accessed October 23, 2026)
  5. Sanz-Cuesta T et al. Oral versus intramuscular administration of vitamin B12 for vitamin B12 deficiency in primary care (OB12). BMJ Open 2020;10:e033687. https://doi.org/10.1136/bmjopen-2019-033687 (accessed October 23, 2026)
  6. NIH Office of Dietary Supplements. Vitamin B12: Fact Sheet for Health Professionals. Updated July 2, 2025. https://ods.od.nih.gov/factsheets/VitaminB12-HealthProfessional/ (accessed October 23, 2026)
  7. MHRA. Metformin and reduced vitamin B12 levels: new advice for monitoring patients at risk. Drug Safety Update, June 2022. https://www.gov.uk/drug-safety-update/metformin-and-reduced-vitamin-b12-levels-new-advice-for-monitoring-patients-at-risk (accessed October 23, 2026)
  8. Social Security Institution (SGK). Sağlık Uygulama Tebliği Ek-4/A Bedeli Ödenecek İlaçlar Listesi [Health Implementation Communiqué Annex 4/A List of Reimbursed Medicines] (incorporating the amendment in the Official Gazette (Resmî Gazete) of October 2, 2026, No. 33388). https://sgk.gov.tr/duyuru/detay/02102026-Tarihli-ve-33388-Sayili-Resm-Gazetede-Yayimlanan-Sosyal-Guvenlik-Kurumu-Saglik-Uygulama-Tebliginde-Degisiklik-Yapilmasina-Dair-Teblig-2026-10-02-02-48-55 (accessed October 24, 2026)
  9. TİTCK. Vitamin B1, B6 and B12 combination film-coated tablet (250 mg/250 mg/1 mg) Summary of Product Characteristics, sections 2, 4.2 and 4.9. TİTCK-approved SmPC (PDF) (accessed October 24, 2026)
  10. TİTCK. SKRS E-Reçete İlaç ve Diğer Farmasötik Ürünler Listesi ve Ruhsatlı Beşeri Tıbbi Ürünler Listesi [SKRS E-Prescription List of Medicines and Other Pharmaceutical Products and List of Licensed Medicinal Products for Human Use] (hydroxocobalamin combinations, ATC B03BA53). https://www.titck.gov.tr/dinamikmodul/43 (accessed October 24, 2026)
  11. NHS. Vitamin B12 or folate deficiency anaemia – Treatment. https://www.nhs.uk/conditions/vitamin-b12-or-folate-deficiency-anaemia/treatment/ (accessed October 24, 2026)
  12. EFSA. Overview on Tolerable Upper Intake Levels as derived by the SCF and the EFSA NDA Panel. https://www.efsa.europa.eu/sites/default/files/2024-05/ul-summary-report.pdf (accessed October 23, 2026)
  13. TİTCK. Summaries of Product Characteristics of combination IM ampoules containing hydroxocobalamin, B6, B1 and lidocaine (two products), sections 2, 4.2, 4.3 and 4.6. TİTCK-approved SmPC 1 (PDF); TİTCK-approved SmPC 2 (PDF) (accessed October 24, 2026)

Frequently asked questions

Is a B12 injection good for tiredness?

If there is no deficiency, no. There is no guideline recommendation showing that the injection provides additional benefit when there is no deficiency. Other causes of tiredness are investigated. An injection given before the test can hide the deficiency in the later test.

In how many days does a B12 injection start to work?

A person generally starts to feel better in the first day or two. According to NICE 2024, symptoms can start to improve within 2 weeks, but this can take up to 3 months. The blood count returns to normal in 6–8 weeks. Nerve findings improve more slowly; long-standing damage may not go away completely.

Are B12 tablets as effective as injections?

In the short term they can correct the blood level in a way similar to injections. According to Cochrane 2018, tablets of 1,000 µg a day were not found to be clinically different from injections, but the evidence is of low certainty. In the 52-week OB12 trial, the rate of normal levels was 73.6% with tablets and 80.4% with injections; but the tablet group took a once-weekly dose in maintenance and the difference is not certain. In permanent loss of absorption and in severe nerve findings, injections have a separate place.

How many days apart are B12 injections given?

There is no single regimen; your doctor sets the schedule. In one example in the Turkish guideline the injection is given every day in the first week, then 2 days a week for 2 weeks, then once a week for 1–2 weeks, and after that it moves to once a month. In maintenance, cyanocobalamin is given once a month and hydroxocobalamin once every two to three months.

Are B12 injections for life in pernicious anemia?

Yes. According to NICE 2024, intramuscular B12 is recommended for life in autoimmune gastritis (pernicious anemia). Treatment continues even if symptoms go away, because the cause is permanent. If it is stopped, the deficiency can develop again.

Is sublingual or methyl B12 absorbed better?

No, the word "sublingual" on its own does not show superiority. For a non-prescription product, NICE accepts all three of cyanocobalamin, methylcobalamin and adenosylcobalamin. What is decisive is the dose and regular use.

Source: Türk Hematoloji Derneği. Eritrosit Hastalıkları ve Hemoglobin Bozuklukları Tanı ve Tedavi Kılavuzu (B12 Vitamini Eksikliği bölümü). Sürüm 1.4, Ağustos 2025.